Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer
Preprint
- 25 November 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
The evolution from low grade to metastatic tumour is a major determinant of cancer mortality. Cancer evolution involves a complex interplay between intrinsic genetics and transcriptional alterations and the microenvironment. To define mechanisms underpinning metastatic development, we focused on metastatic castration-resistant prostate cancer (mCRPC) and employed single-cell multi-omics and whole-genome sequencing to deeply profile 34 metastatic lesions from 9 patients by rapid autopsy. We found that intra-tumour heterogeneity is an indicator of key evolutionary processes, characterised by recurrent tumour populations acting as critical functional components of the tumour ecosystem, irrespective of clonal and microenvironmental backgrounds. Unexpectedly, microenvironments only played a limited role while clonal evolution primarily promoted transcriptional noise. Intra-patient functional convergence of tumour ecosystems was observed across metastases, showing system-level selection pressures that drive the heterogeneity landscape of mCRPC. Our findings reveal functional evolutionary convergence of metastatic disease into units of intra-tumour heterogeneity, identifying critical determinants for therapeutic targeting. *Co-senior authors: Anna S. Trigos & Shahneen Sandhu contributed equally to this work.Keywords
All Related Versions
This publication has 88 references indexed in Scilit:
- Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancerCell Systems, 2022
- Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate canceriScience, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand TherapyEuropean Urology Oncology, 2019
- Atlas of Subcellular RNA Localization Revealed by APEX-SeqCell, 2019
- A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic UrethraCell Reports, 2018
- Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration ResistanceCancer Cell, 2017
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Improving the Assessment of the Outcome of Nonsynonymous SNVs with a Consensus Deleteriousness Score, CondelThe American Journal of Human Genetics, 2011
- DNA methyltransferase and demethylase in human prostate cancerMolecular Carcinogenesis, 2002